vs
科睿唯安（CLVT）与医疗房产信托（SVC）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是医疗房产信托的2.0倍（$585.5M vs $296.5M），医疗房产信托净利率更高（-0.3% vs -6.9%，领先6.6%），科睿唯安同比增速更快（-1.4% vs -17.0%），科睿唯安自由现金流更多（$78.9M vs $-95.2M），过去两年科睿唯安的营收复合增速更高（-5.1% vs -6.1%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
医疗房产信托（MPT）是总部位于阿拉巴马州伯明翰的国际房地产投资信托（REIT），主要在美国和欧洲地区收购投资医疗设施与营利性医疗控股公司。该公司的房产收购多采用售后回租模式，原产权方出售房产给MPT后成为承租租户，其租户普遍签订长期三净租约。
CLVT vs SVC — 直观对比
营收规模更大
CLVT
是对方的2.0倍
$296.5M
营收增速更快
CLVT
高出15.6%
-17.0%
净利率更高
SVC
高出6.6%
-6.9%
自由现金流更多
CLVT
多$174.1M
$-95.2M
两年增速更快
CLVT
近两年复合增速
-6.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $585.5M | $296.5M |
| 净利润 | $-40.2M | $-782.0K |
| 毛利率 | 67.2% | — |
| 营业利润率 | 5.2% | -3.9% |
| 净利率 | -6.9% | -0.3% |
| 营收同比 | -1.4% | -17.0% |
| 净利润同比 | 61.3% | 99.0% |
| 每股收益（稀释后） | $-0.06 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTSVC
| Q1 26 | $585.5M | — | ||
| Q4 25 | $617.0M | $296.5M | ||
| Q3 25 | $623.1M | $377.6M | ||
| Q2 25 | $621.4M | $404.4M | ||
| Q1 25 | $593.7M | $335.0M | ||
| Q4 24 | $663.0M | $357.0M | ||
| Q3 24 | $622.2M | $390.9M | ||
| Q2 24 | $650.3M | $412.5M |
净利润CLVTSVC
| Q1 26 | $-40.2M | — | ||
| Q4 25 | $3.1M | $-782.0K | ||
| Q3 25 | $-28.3M | $-46.9M | ||
| Q2 25 | $-72.0M | $-38.2M | ||
| Q1 25 | $-103.9M | $-116.4M | ||
| Q4 24 | $-191.8M | $-76.4M | ||
| Q3 24 | $-65.6M | $-46.9M | ||
| Q2 24 | $-304.3M | $-73.8M |
毛利率CLVTSVC
| Q1 26 | 67.2% | — | ||
| Q4 25 | 66.8% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 67.2% | — | ||
| Q1 25 | 65.1% | — | ||
| Q4 24 | 65.7% | — | ||
| Q3 24 | 66.2% | — | ||
| Q2 24 | 67.2% | — |
营业利润率CLVTSVC
| Q1 26 | 5.2% | — | ||
| Q4 25 | 6.7% | -3.9% | ||
| Q3 25 | 7.1% | -12.8% | ||
| Q2 25 | 1.1% | -9.2% | ||
| Q1 25 | -3.5% | -33.3% | ||
| Q4 24 | -9.4% | -19.4% | ||
| Q3 24 | 3.5% | -12.8% | ||
| Q2 24 | -36.9% | -17.1% |
净利率CLVTSVC
| Q1 26 | -6.9% | — | ||
| Q4 25 | 0.5% | -0.3% | ||
| Q3 25 | -4.5% | -12.4% | ||
| Q2 25 | -11.6% | -9.4% | ||
| Q1 25 | -17.5% | -34.8% | ||
| Q4 24 | -28.9% | -21.4% | ||
| Q3 24 | -10.5% | -12.0% | ||
| Q2 24 | -46.8% | -17.9% |
每股收益（稀释后）CLVTSVC
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $0.00 | $-0.01 | ||
| Q3 25 | $-0.04 | $-0.28 | ||
| Q2 25 | $-0.11 | $-0.23 | ||
| Q1 25 | $-0.15 | $-0.70 | ||
| Q4 24 | $-0.27 | $-0.46 | ||
| Q3 24 | $-0.09 | $-0.28 | ||
| Q2 24 | $-0.46 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $346.8M |
| 总债务越低越好 | $4.3B | $5.5B |
| 股东权益账面价值 | $4.8B | $646.1M |
| 总资产 | $10.9B | $6.5B |
| 负债/权益比越低杠杆越低 | 0.89× | 8.52× |
8季度趋势，按日历期对齐
现金及短期投资CLVTSVC
| Q1 26 | — | — | ||
| Q4 25 | $329.2M | $346.8M | ||
| Q3 25 | $318.7M | $417.4M | ||
| Q2 25 | $362.6M | $63.2M | ||
| Q1 25 | $354.0M | $80.1M | ||
| Q4 24 | $295.2M | $143.5M | ||
| Q3 24 | $388.5M | $48.6M | ||
| Q2 24 | $376.4M | $14.6M |
总债务CLVTSVC
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $5.5B | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | $5.8B | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — |
股东权益CLVTSVC
| Q1 26 | $4.8B | — | ||
| Q4 25 | $4.8B | $646.1M | ||
| Q3 25 | $4.9B | $647.9M | ||
| Q2 25 | $5.0B | $695.9M | ||
| Q1 25 | $5.0B | $734.6M | ||
| Q4 24 | $5.1B | $851.9M | ||
| Q3 24 | $5.5B | $929.0M | ||
| Q2 24 | $5.6B | $1.0B |
总资产CLVTSVC
| Q1 26 | $10.9B | — | ||
| Q4 25 | $11.1B | $6.5B | ||
| Q3 25 | $11.2B | $7.0B | ||
| Q2 25 | $11.4B | $6.9B | ||
| Q1 25 | $11.5B | $7.0B | ||
| Q4 24 | $11.5B | $7.1B | ||
| Q3 24 | $12.0B | $7.1B | ||
| Q2 24 | $12.1B | $7.1B |
负债/权益比CLVTSVC
| Q1 26 | 0.89× | — | ||
| Q4 25 | 0.89× | 8.52× | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | 6.85× | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.7M | $-18.5M |
| 自由现金流经营现金流 - 资本支出 | $78.9M | $-95.2M |
| 自由现金流率自由现金流/营收 | 13.5% | -32.1% |
| 资本支出强度资本支出/营收 | 9.5% | 25.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $333.9M | $-107.0M |
8季度趋势，按日历期对齐
经营现金流CLVTSVC
| Q1 26 | $134.7M | — | ||
| Q4 25 | $159.9M | $-18.5M | ||
| Q3 25 | $181.1M | $98.1M | ||
| Q2 25 | $116.3M | $-7.0K | ||
| Q1 25 | $171.2M | $38.2M | ||
| Q4 24 | $141.3M | $-9.7M | ||
| Q3 24 | $202.9M | $106.2M | ||
| Q2 24 | $126.2M | $43.8M |
自由现金流CLVTSVC
| Q1 26 | $78.9M | — | ||
| Q4 25 | $89.2M | $-95.2M | ||
| Q3 25 | $115.5M | $57.9M | ||
| Q2 25 | $50.3M | $-46.6M | ||
| Q1 25 | $110.3M | $-23.2M | ||
| Q4 24 | $59.1M | $-88.9M | ||
| Q3 24 | $126.3M | $24.1M | ||
| Q2 24 | $60.3M | $-22.3M |
自由现金流率CLVTSVC
| Q1 26 | 13.5% | — | ||
| Q4 25 | 14.5% | -32.1% | ||
| Q3 25 | 18.5% | 15.3% | ||
| Q2 25 | 8.1% | -11.5% | ||
| Q1 25 | 18.6% | -6.9% | ||
| Q4 24 | 8.9% | -24.9% | ||
| Q3 24 | 20.3% | 6.2% | ||
| Q2 24 | 9.3% | -5.4% |
资本支出强度CLVTSVC
| Q1 26 | 9.5% | — | ||
| Q4 25 | 11.5% | 25.9% | ||
| Q3 25 | 10.5% | 10.6% | ||
| Q2 25 | 10.6% | 11.5% | ||
| Q1 25 | 10.3% | 18.3% | ||
| Q4 24 | 12.4% | 22.2% | ||
| Q3 24 | 12.3% | 21.0% | ||
| Q2 24 | 10.1% | 16.0% |
现金转化率CLVTSVC
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
SVC
暂无分部数据
